Detalhe da pesquisa
1.
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Asian Pac J Allergy Immunol;
40(3): 223-231, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32247304